Dawn Health

Dawn Health

Private
Copenhagen, Capital Region of DenmarkHealthcare & Life Scienceshttps://dawnhealth.com

Last Round

Early Funding

Feb 10, 2026

Total Funding Raised

$63.69M

Company Overview

Dawn Health is a Danish digital health company founded in 2016 that specializes in Software as a Medical Device (SaMD) and Digital Therapeutics (DTx). The company provides its platform and product suite to global pharmaceutical companies, including Merck and Novartis, through a Software-as-a-Service (SaaS) model. Its solutions are used in therapeutic areas such as oncology, multiple sclerosis, and rare pediatric conditions to help patients manage treatment, report symptoms, and enable healthcare professionals to improve care. Dawn Health aims to generate real-world evidence and improve patient outcomes through its digital products.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Patient Engagement, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

Software as a Medical DeviceSaMDDigital TherapeuticsDTxtherapy companion apppharma digital healthreal-world evidenceRWEpatient engagement platformbeyond the pillchronic disease managementregulated softwareremote monitoringISO 13485prescription digital therapeuticspharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dawn Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Dawn Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 10, 2026
Early FundingMay 5, 2025
Series ADec 1, 2021

Key People

Founding team and executive leadership

Alexander Mandix Hansen

CEO

Executive Team

Michael Håkan

Chief Financial Officer

Executive Team

Anne-Sofie Nielsen

COO CTO

Executive Team

Dawn Health Investors

Notable investors and investment history

InvestorRounds
Chr. Augustinus FabrikkerEarly Funding, Series A
The Export and Investment Fund of DenmarkEarly Funding, Series A
Cipio PartnersEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2025

    $13.1M raised in early funding.

  • Feb 10, 2025

    Partnered to launch Cora BC app for breast cancer patients.

Dawn Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dawn Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dawn Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Employee Range114
Year Founded2016
Last FundingFeb 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.